MIS "Dementia"

Abstract

The proportion of individuals affected by dementia worldwide currently stands at over one percent and is anticipated to double within the next 20 years. Meanwhile, the accuracy of diagnosing the prevalent type of dementia, Alzheimer's disease, remains below 10%. The absence of uniform diagnostic criteria for each type of dementia is a major factor contributing to misdiagnosis. Poor detection results, coupled with the lack of profound treatment methods, places dementia among the main threats to public health. The research team from Semashko National Research Institute successfully structured and digitized diagnostic criteria for the main forms of dementia, resulting in the creation of MIS "Dementia" basing on the 1C web platform (MIS — certificate No. 2022664724 dated July 22, 2022), intended for diagnosis, out-of-office monitoring and treatment of 44 forms diseases. After the clinical trials are finished and the MIS is approved, it will be implemented in the organization of memory impairment clinics.